Jerome S. Tannenbaum, M.D., Ph.D. FACP – Founding Chairman
Dr. Tannenbaum was the Founder, Chairman, and CEO of 3 of the largest dialysis companies in the United States. He founded and led REN Corporation-USA (NASDAQ:RENL) from its inception in 1986 to becoming the 4th largest dialysis provider in the United States in 1993, and through its IPO in 1989. He sold his interests to Gambro AB in 1993 for an implied company valuation of $320 million. He was the Founder, Chairman, and CEO of National Nephrology Associates from its inception in 1998 until 2003 when it was the 4th largest dialysis provider in the United States. NNA was acquired by Renal Care Group (NYSE:RCG) in 2004 for $385 Million. He was the Founder, Chairman and CEO of DSI Renal in 2005 and led DSI to become the 4th largest dialysis provider in the United States by the time he left the Company in 2009. DSI was acquired by DaVita for $735 Million in 2011. He is the Founder, Chairman, and the CEO of Sanderling Renal Services which he co-founded with Deborah Tannenbaum and Dr. Rajeev Prasad in late 2012.
Dr. Tannenbaum holds an M.D. from Vanderbilt University School of Medicine and a Ph.D. in Pharmacology from Vanderbilt University School of Graduate Studies. He completed his training in Internal Medicine at the Jewish Hospital of St. Louis and his Nephrology training at Barnes Hospital, both affiliates of Washington University of St. Louis School of Medicine. He is Board Certified in Internal Medicine and Nephrology and is a Fellow of the American College of Physicians (FACP). He was the founder of REN Corporation-USA (formerly NASDAQ: RENL), a publicly traded provider of dialysis services, where he served as President, Chairman and Chief Executive Officer from 1987 to 1993. In 1993, he founded Medical Information Management Systems, Inc. (MIMS), a medical software company and developer of the robust PEARL EMR system. In 1998, Dr. Tannenbaum became Chairman and Chief Executive Officer of National Nephrology Associates, Inc. (NNA), a nationwide dialysis services provider that he co-founded with some of his original management team from REN.
Dr. Tannenbaum left NNA in June 2003 to co-found Diversified Specialty Institutes, Inc. (DSI) with Dr. G. Patrick Maxwell, and certain former members of the NNA, MIMS, and REN management teams. In 2005, Dr. Tannenbaum led the formation and expansion of DSI Renal, Inc. (an affiliate of DSI), a company that operates over 120 dialysis centers across 26 states, and served as its Chairman and Chief Executive Officer. In late 2008, Dr. Tannenbaum left DSI Renal in order to found Sanderling Healthcare, LLC, to commercialize his pre-engineered construction methodology for hospitals and other healthcare facilities.